CausalSentinel

Protein Dossier — FGFBP3 (Fibroblast growth factor-binding protein 3)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Years of schooling 0.043 0.0132 0.00115 Wald ratio 1 cis NA
Underlying (primary) cause of death: ICD10: E85.4 Organ-limited amyloidosis 1.55 0.551 0.00484 Wald ratio 1 cis NA
Diagnoses - main ICD10: N81 Female genital prolapse 0.155 0.0618 0.0119 Wald ratio 1 cis NA
Body mass index (BMI) -0.0215 0.0086 0.0123 Wald ratio 1 cis NA
Fasting insulin 0.0331 0.0132 0.0124 Wald ratio 1 cis NA
HOMA-B 0.0563 0.0232 0.0152 Wald ratio 1 cis NA
Alcohol intake frequency -0.0298 0.0127 0.0193 Wald ratio 1 cis NA
Pulse rate -0.0337 0.0152 0.0266 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities 0.119 0.0535 0.0268 Wald ratio 1 cis NA
Eczema 0.125 0.0614 0.0419 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes 0.0285 0.0144 0.0486 Wald ratio 1 cis NA
Potassium in urine 0.0171 0.00873 0.0504 Wald ratio 1 cis NA
…and 94 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

61 association rows across 40 traits (57 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Fibroblast growth factor-binding protein 3 levels 2e-179 rs58519543 1 GCST90247596 no MR -> candidate analysis
FGFBP3 protein levels 4e-89 rs79183014 4 GCST90469232 no MR -> candidate analysis
Sex hormone-binding globulin levels adjusted for BMI 9e-54 rs1772189 2 GCST90012110 no MR -> candidate analysis
Serum levels of protein FGFBP3 1e-51 rs11186737 1 GCST90086618 no MR -> candidate analysis
Sex hormone-binding globulin levels 7e-39 rs1772189 6 GCST90012111 no MR -> candidate analysis
Blood protein levels 6e-28 rs11186737 1 GCST006585 no MR -> candidate analysis
Alkaline phosphatase (UKB data field 30610) 3e-18 rs1890896 1 GCST90468060 no MR -> candidate analysis
Liver enzyme levels (alkaline phosphatase) 4e-18 rs1890896 1 GCST90013406 no MR -> candidate analysis
Fibroblast growth factor-binding protein 3 level in Chronic 6e-16 rs74149314 1 GCST90233133 no MR -> candidate analysis
Free Cholesterol to Cholesteryl Esters in Very Large HDL rat 6e-15 rs11186740 1 GCST90828013 no MR -> candidate analysis
Height (baseline) 7e-15 rs68185109 3 GCST90565843 no MR -> candidate analysis
Height 1e-14 rs76264073 1 GCST007841 MR: beta=0.0139, p=0.269 (cis)
…and 28 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 49 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
myocardial infarction 0.224 common-variant locus no MR -> candidate analysis
diabetic ketoacidosis 0.174 common-variant locus no MR -> candidate analysis
lung disorder 0.14 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.097 common-variant locus no MR -> candidate analysis
adolescent idiopathic scoliosis 0.094 common-variant locus no MR -> candidate analysis
placenta praevia 0.084 common-variant locus no MR -> candidate analysis
exostosis 0.084 common-variant locus no MR -> candidate analysis
smoking initiation 0.079 common-variant locus no MR -> candidate analysis
edema 0.075 common-variant locus no MR -> candidate analysis
brain compression 0.075 common-variant locus no MR -> candidate analysis
intelligence 0.075 common-variant locus no MR -> candidate analysis
migraine disorder 0.056 common-variant locus no MR -> candidate analysis
metabolic syndrome 0.034 common-variant locus no MR -> candidate analysis

Of the 13 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.033, LOEUF=1.9 — LoF-tolerant
GWAS Catalog 66 unique SNPs / 132 rows
ClinVar 79 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance